Active Ingredient(s): Naldemedine
FDA Approved: * March 23, 2017
Pharm Company: * SHIONOGI INC
Category: Opioid Dependence

Naldemedine (brand name Symproic in the US and Rizmoic in the European Union) is a medication that is used for the treatment of opioid-induced constipation in adults with chronic non-cancer pain. It is a peripherally acting μ-opioid receptor antagonist and was developed by Shionogi.[1] Clinical studies have found it to possess statistically significant effectiveness for these indications and to be generally well tolerated, with predominantly mild to moderate gastrointesti... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Symproic .2 mg Oral Tablet
NDC: 59011-523
Purdue Pharma Lp
Symproic .2 mg Oral Tablet
NDC: 59385-041
Biodelivery Sciences International Inc
Symproic .2 mg Oral Tablet
NDC: 59630-222
Shionogi Inc.

Popular Topics

Uses of Symproic pills / New med!

Can Symproic be used for other colon problems besides that which is related to opioid use? I don't take opioids but ...